Beam Therapeutics Inc. — Director's Dealing 2022

Sep 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beam Therapeutics Inc. (BEAM)
CIK: 0001745999
Period of Report: 2022-09-01

Reporting Person: MARAGANORE JOHN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-01	Stock Option (Right to Buy)	$55.58	A	10391	Acquired	2032-09-01	Common Stock (10391)	Direct

Footnotes

F1: The option vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date.